Earlier onset of treatment improves the nephroprotective effect of dapagliflozin

• Antonio Gippini,
• Alberto Prado

Affiliations

Antonio Gippini

Endocrinologist, Endocrinology Service, Hospitalary Complex Ourense, National Health System, Spain; Corresponding author.

Alberto Prado

Pharmacist, Master in Statistics, Cardiovascular Renal Metabolism (CVRM), Medical Department, AstraZeneca, Spain